Neotrofin clinical trials show promise.
D000544:Alzheimer Disease / Q000188:drug therapy*; D062365:Aminobenzoates; D017322:Clinical Trials, Phase II as Topic; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D006801:Humans; D007042:Hypoxanthines; D018697:Nootropic Agents / Q000008:administration & dosage*; D010865:Pilot Projects; D011687:Purines
D062365:Aminobenzoates; D007042:Hypoxanthines; D018697:Nootropic Agents; D011687:Purines; C086241:4-((3-(1,6-dihyro-6-oxo-9H-purin-9-yl)-1-oxopropyl)amino)benzoic acid